Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Emergence and mechanisms of multi-drug resistant microorganisms in high-risk patients

FY 2019-20

Summary
"Antimicrobial resistance (AMR) is a major threat to clinical medicine. Hospitals serve as prominent reservoirs for AMR, contributing to the development of deadly multi-drug resistant (MDR) pathogens. There remains a substantial need for current surveillance of resistance trends in hospitals and further study into how AMR bacteria arise in patients to cause treatment failure. Understanding how AMR organisms arise in individual patients at high risk (e.g. those receiving prophylactic antibiotics) can provide insights into management of AMR We have undertaken a study of acute myeloid leukemia (AML) patients, receiving high dose prophylactic antibiotics. AMR bacteria were isolated from longitudinal patient samples to create a library of ~960 isolates. I propose the following aims: 1) to identify MDR bacteria and track resistance development over time; 2) Use whole genome sequencing (WGS) and comparative genomics to characterize mechanisms of resistance. Aim 1. I have screened ~960 isolates using an inclusive panel of antibiotics and 90% of isolates have been identified. Preliminary data shows bacteria that develop MDR over time and pathogens resistant to colistin, the last resort antibiotic. We also observed ~27 hetero-resistant strains. I will explore resistance evolution in these strains and further characterize observed hetero-resistance. Aim 2. Whole genome sequencing and comparative genomics will be used to identify resistance mechanisms and track strain or gene acquisitions over time. In addition, we will carry out the same approach to understand hetero-resistance evolution in vivo and in vitro. These results will serve to provide insight into MDR pathogens and AMR genes circulating within hospitals, and measure of how much AMR evolves within patients. "
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428983
Name
Mech Eugene A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Emergence and mechanisms of multi-drug resistant microorganisms in high-risk patients
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Hetero-Resistance; Microbiology; Multi-Drug Resistance
Abstract
"Antimicrobial resistance (AMR) is a major threat to clinical medicine. Hospitals serve as prominent reservoirs for AMR, contributing to the development of deadly multi-drug resistant (MDR) pathogens. There remains a substantial need for current surveillance of resistance trends in hospitals and further study into how AMR bacteria arise in patients to cause treatment failure. Understanding how AMR organisms arise in individual patients at high risk (e.g. those receiving prophylactic antibiotics) can provide insights into management of AMR We have undertaken a study of acute myeloid leukemia (AML) patients, receiving high dose prophylactic antibiotics. AMR bacteria were isolated from longitudinal patient samples to create a library of ~960 isolates. I propose the following aims: 1) to identify MDR bacteria and track resistance development over time; 2) Use whole genome sequencing (WGS) and comparative genomics to characterize mechanisms of resistance. Aim 1. I have screened ~960 isolates using an inclusive panel of antibiotics and 90% of isolates have been identified. Preliminary data shows bacteria that develop MDR over time and pathogens resistant to colistin, the last resort antibiotic. We also observed ~27 hetero-resistant strains. I will explore resistance evolution in these strains and further characterize observed hetero-resistance. Aim 2. Whole genome sequencing and comparative genomics will be used to identify resistance mechanisms and track strain or gene acquisitions over time. In addition, we will carry out the same approach to understand hetero-resistance evolution in vivo and in vitro. These results will serve to provide insight into MDR pathogens and AMR genes circulating within hospitals, and measure of how much AMR evolves within patients. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mech, Eugene A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~